Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015.

CONCLUSION: The epidemiological characteristics of recipient VAPP cases in China, such as age distribution, were comparable to those in previous studies from other countries. The risk of recipient VAPP, using either estimated births or vaccination doses, was comparable to that in the US and Japan. We recommend using an inactive poliovirus vaccine to decrease the number of recipient VAPP cases in China. PMID: 29395524 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29395524?dopt=Abstract

Source: Vaccine - January 25, 2018 Category: Allergy & Immunology Authors: Wu W, Wang H, Li K, Pekka Nuorti J, Liu D, Xu D, Ye J, Zheng J, Fan C, Wen N, An Z Tags: Vaccine Source Type: research